Nature reporter Elie Dolgin writes about Prof. Pierre Azoulay’s new research that shows NIH funding has a significant impact on innovation in the field of biomedicine. Azoulay explains that from an economic standpoint the U.S. is “under-investing overall” in biomedical research.
Los Angeles Times reporter Melissa Healy writes that a new study by Prof. Pierre Azoulay examining the impact of NIH-funded research shows that NIH funding, “fuels the kinds of innovations that drive the U.S. economy.” Azoulay explains, “NIH public funding expenditures have large effects on the patenting output of the private sector.”
A study by Prof. Pierre Azoulay demonstrates the significant impact of NIH funding on biomedical patents, reports Carolyn Johnson for The Washington Post. Azoulay explains, “if your view was that the research done by academics...[has] no ramifications for the real world and the development of new medicines — well, that view is not correct.”
New Scientist reporter Sam Wong writes that MIT researchers used high-speed cameras to examine how raindrops can spread soil bacteria. “The researchers estimate that a single raindrop can transfer 0.01 per cent of bacteria on the soil surface into the air, and up to a quarter of bacteria emitted from the land might become airborne in this way.”
Using high-speed cameras and fluorescent dye, MIT researchers have uncovered how rain drops can spread soil bacteria, reports Rae Ellen Bichell for NPR. The researchers found that in a few microseconds “a single raindrop can create hundreds of tiny airborne droplets, each one carrying as many as several thousand live bacteria.”
Popular Science reporter Kendra Pierre-Louis writes about a new study by MIT researchers that examines how rain drops help spread soil bacteria. The researchers found that “a single rain drop can transfer 0.01 percent of bacteria on the soil surface to the atmosphere.”
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
In this piece for The New Yorker, Michael Specter writes about Prof. Kevin Esvelt’s idea to use gene-editing technology to eradicate Lyme disease. “This is an ecological problem,” Esvelt explains. “And we want to enact an ecological solution so that we break the transmission cycle that keeps ticks in the environment infected with these pathogens.”
In an article for Popular Science, Kate Baggaley speaks with Prof. Timothy Lu and postdoc César de la Fuente about strategies they are developing to tackle antibiotic resistance. Lu explains that researchers are attempting to develop an arsenal of treatments to “be able to come at the problem from a variety of different ways.”
A new drug delivery system developed by MIT researchers may help eradicate malaria and could boost medication adherence, writes Rachel Zimmerman for WBUR’s Bostonomix. "People don't take their medicines and this might be a way, someday, for Alzheimer's patients to have much better treatments and people with mental health diseases to have much better treatments," says Prof. Langer.
MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”
Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”
MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”
Researchers at MIT have developed a slow-release drug capsule that can last two weeks in a person’s stomach, writes Jamie Ducharme for Boston Magazine. “The capsule was tested for use in malaria prevention, but the researchers behind it say it could be used for virtually any condition that requires regular oral medication,” Ducharme explains.